Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F J Broekmans

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Climacteric : the Journal of the International Menopause Society|May 14, 2016
Age-specific anti-Müllerian hormone and electrocardiographic silent coronary artery diseaseF Ramezani Tehrani, S A Montazeri, D Khalili, et al.
Fertility and Sterility|February 26, 2000
Basal follicle-stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilizationL F Bancsi, A M Huijs, C T den Ouden, et al.
Journal of Assisted Reproduction and Genetics|April 23, 2005
Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVFD J Hendriks, F J Broekmans, L F J M M Bancsi, et al.
Human Reproduction (Oxford, England)|May 9, 2007
Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVFM F G Verberg, M J C Eijkemans, N S Macklon, et al.
Human Reproduction (Oxford, England)|November 17, 2012
The association of CGG repeats in the FMR1 gene and timing of natural menopauseM Voorhuis, N C Onland-Moret, B C J M Fauser, et al.
Human Reproduction (Oxford, England)|October 31, 2014
Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormoneO Hamdine, M J C Eijkemans, E W G Lentjes, et al.
Human Reproduction Update|September 17, 2010
Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysisM D Sterrenburg, S M Veltman-Verhulst, M J C Eijkemans, et al.
Human Reproduction (Oxford, England)|December 20, 2008
Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteriaA J Goverde, A J B van Koert, M J Eijkemans, et al.
Human Reproduction (Oxford, England)|June 12, 2008
Why do couples drop-out from IVF treatment? A prospective cohort studyM F G Verberg, M J C Eijkemans, E M E W Heijnen, et al.
Human Reproduction (Oxford, England)|December 7, 2011
Complications and outcome of assisted reproduction technologies in overweight and obese womenA M H Koning, M A Q Mutsaerts, W K H Kuchenbecker, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Climacteric : the Journal of the International Menopause Society|May 14, 2016
Age-specific anti-Müllerian hormone and electrocardiographic silent coronary artery diseaseF Ramezani Tehrani, S A Montazeri, D Khalili, et al.
Fertility and Sterility|February 26, 2000
Basal follicle-stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilizationL F Bancsi, A M Huijs, C T den Ouden, et al.
Journal of Assisted Reproduction and Genetics|April 23, 2005
Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVFD J Hendriks, F J Broekmans, L F J M M Bancsi, et al.
Human Reproduction (Oxford, England)|May 9, 2007
Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVFM F G Verberg, M J C Eijkemans, N S Macklon, et al.
Human Reproduction (Oxford, England)|November 17, 2012
The association of CGG repeats in the FMR1 gene and timing of natural menopauseM Voorhuis, N C Onland-Moret, B C J M Fauser, et al.
Human Reproduction (Oxford, England)|October 31, 2014
Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormoneO Hamdine, M J C Eijkemans, E W G Lentjes, et al.
Human Reproduction Update|September 17, 2010
Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysisM D Sterrenburg, S M Veltman-Verhulst, M J C Eijkemans, et al.
Human Reproduction (Oxford, England)|December 20, 2008
Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteriaA J Goverde, A J B van Koert, M J Eijkemans, et al.
Human Reproduction (Oxford, England)|June 12, 2008
Why do couples drop-out from IVF treatment? A prospective cohort studyM F G Verberg, M J C Eijkemans, E M E W Heijnen, et al.
Human Reproduction (Oxford, England)|December 7, 2011
Complications and outcome of assisted reproduction technologies in overweight and obese womenA M H Koning, M A Q Mutsaerts, W K H Kuchenbecker, et al.
Pageof 5